Evidence map›Paper›PMID 32023739›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2019

[The correlations and prognostic value of neutrophil to lymphocyte ratio, immunophenotype and cytogenetic abnormalities in patients with newly diagnosed multiple myeloma].

J J Hu, S M Nie, Y Gao, X S Yan, J X Huang, T L Li, S S Liu, C X Mao, J J Zhou, Y J Xu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. suPAR: An Inflammatory Mediator for Kidneys.Kidney diseases (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

J J HuDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
S M NieDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
Y GaoDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
X S YanDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
J X HuangDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
T L LiDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
S S LiuDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
C X MaoDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
J J ZhouDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
Y J XuDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
W WangDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
F J MengDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
X Q FengDepartment of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaChromosome AberrationsHumansLymphocytesNeutrophilsPrognosis

Identifiers

PMID32023739
PMCPMC7342691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.